Indiplon is still in phase three development
McGarry Bowen, an independent agency that started a year ago, now has business from Pfizer, Marriott and Verizon. The agency beat out four other undisclosed contenders in the Indiplon review.
Indiplon will enter the category to compete against market leader Ambien, made by Sanofi-Synthelabo, Paris. Sanofi spent $23 million in measured media on Ambien through September of last year, according to TNS Media Intelligence/CMR.